Recent Finacing
Recent Raise
Alexar Therapeutics develops Liver X receptor (LXR) agonists— including topical candidate A-110—for systemic and dermatologic indications and operates as an independent asset-focused company spun out by NeXeption.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors